February 19, 2017 11:07 PM ET

Life Sciences Tools and Services

Company Overview of Adaptive Biotechnologies Corporation

Company Overview

Adaptive Biotechnologies Corporation is engaged in combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors. The company offers immunosequencing platform to laboratories around the world to drive research in cancer and other immune-mediated diseases. It also translates immunosequencing discoveries into clinical diagnostics and therapeutic development to improve patient care. Adaptive Biotechnologies Corporation has a strategic research agreement with Argos Therapeutics, Inc. Adaptive Biotechnologies Corporation was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in January 2012. The company w...

1551 Eastlake Avenue East

Suite 200

Seattle, WA 98102

United States

Founded in 2009

Phone:

206-659-0067

Fax:

206-659-0667

Key Executives for Adaptive Biotechnologies Corporation

Co-Founder, Chief Executive Officer, President and Director
Co-Founder, Chief Scientific Officer and Director
Chief Financial Officer, Director and Chairman of Audit Committee
Age: 41
Vice President and General Counsel
Compensation as of Fiscal Year 2016.

Adaptive Biotechnologies Corporation Key Developments

Heat Biologics Selects Adaptive Biotechnologies to Discover Potential Clinical Biomarkers to Advance Novel Immunotherapies

Heat Biologics Inc. announced that they have advanced their biomarker discovery collaboration with Adaptive Biotechnologies. Adaptive will use its patented immune profiling assay, immunoSEQ™, to enable an in-depth characterization of the immune response to Heat’s ImPACT and ComPACT-based immunotherapies, including HS-410, Heat’s Phase 2 product candidate for non-muscle invasive bladder cancer. The immunoSEQ Assay, when used to evaluate the mechanism of action of the ImPACT platform, provides a significant biomarker identification opportunity to better select patients and accelerate future enrollment based on immune status.

Adaptive Biotechnologies Corporation Presents at UBS Genomics 2.0 Summit, Aug-11-2016 07:30 AM

Adaptive Biotechnologies Corporation Presents at UBS Genomics 2.0 Summit, Aug-11-2016 07:30 AM. Venue: St. Regis Deer Valley, Park City, Utah, United States. Speakers: Chad Robins, Co-Founder, Chief Executive Officer, President and Director.

Argos Therapeutics, Inc. Enters into Strategic Research Agreement with Adaptive Biotechnologies Corporation

Argos Therapeutics, Inc. announced that it is partnering with Adaptive Biotechnologies Corporation to study precise response patterns to Argos investigational immunotherapies. Under the agreement, Adaptive will use its patented immune profiling immunoSEQ Assay to enable a more in-depth characterization of the immune response induced by Argos’s lead product candidate, AGS-003, which is currently being studied in the treatment of metastatic renal cell carcinoma, non-small cell lung cancer, and bladder cancer. In addition, Argos is developing its second Arcelis product candidate, AGS-004, for the treatment and the possible eradication of human immunodeficiency virus (HIV) in patients with HIV-infection or acquired immune deficiency syndrome (AIDS). The application of Adaptive’s immune profiling technology in this setting will enable Argos to further characterize with greater precision the transfer of specific genetic signatures from each patient’s HIV, through AGS-004, to a specific immune response against each patient’s unique virus population.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Adaptive Biotechnologies Corporation, please visit www.adaptivebiotech.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.